14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:INFI
Delisted

Infinity Pharmaceuticals Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.0160
+0 (+0%)
At Close: Dec 28, 2023
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0160 $0.0160 Thursday, 28th Dec 2023 INFI stock ended at $0.0160. During the day the stock fluctuated 0% from a day low at $0.0160 to a day high of $0.0160.
90 days $0.0115 $0.0190
52 weeks $0.0111 $0.770

Historical Infinity Pharmaceuticals prices

Date Open High Low Close Volume
Oct 17, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 16, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 13, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 12, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 11, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 10, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 09, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 06, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 05, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 04, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 03, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 02, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Sep 29, 2023 $0.0160 $0.0190 $0.0115 $0.0160 1 141 812
Sep 28, 2023 $0.0111 $0.0170 $0.0111 $0.0168 313 578
Sep 27, 2023 $0.0180 $0.0180 $0.0111 $0.0125 1 642 244
Sep 26, 2023 $0.0170 $0.0208 $0.0170 $0.0180 231 436
Sep 25, 2023 $0.0202 $0.0235 $0.0156 $0.0170 1 064 381
Sep 22, 2023 $0.0220 $0.0250 $0.0210 $0.0210 613 225
Sep 21, 2023 $0.0220 $0.0240 $0.0220 $0.0235 531 514
Sep 20, 2023 $0.0211 $0.0249 $0.0211 $0.0229 850 326
Sep 19, 2023 $0.0251 $0.0313 $0.0221 $0.0223 1 209 578
Sep 18, 2023 $0.0262 $0.0313 $0.0250 $0.0271 1 336 642
Sep 15, 2023 $0.0745 $0.0348 $0.0261 $0.0261 3 965 075
Sep 14, 2023 $0.0745 $0.0400 $0.0225 $0.0322 6 573 638
Sep 13, 2023 $0.0745 $0.0800 $0.0333 $0.0447 21 379 097
Click to get the best stock tips daily for free!

About Infinity Pharmaceuticals

Infinity Pharmaceuticals Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the tre... INFI Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT